1. Home
  2. TECX vs ZURA Comparison

TECX vs ZURA Comparison

Compare TECX & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.27

Market Cap

554.1M

Sector

N/A

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.21

Market Cap

521.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
ZURA
Founded
2019
2022
Country
United States
United States
Employees
60
30
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
554.1M
521.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
ZURA
Price
$29.27
$5.21
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$75.20
$13.00
AVG Volume (30 Days)
189.7K
604.0K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$0.99
52 Week High
$35.99
$7.25

Technical Indicators

Market Signals
Indicator
TECX
ZURA
Relative Strength Index (RSI) 50.66 41.74
Support Level $28.31 $3.33
Resistance Level $31.88 $5.82
Average True Range (ATR) 1.53 0.34
MACD -0.17 -0.03
Stochastic Oscillator 48.05 34.34

Price Performance

Historical Comparison
TECX
ZURA

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: